Sui Xinke, Chen Yan, Liu Baojun, Li Lianyong, Huang Xin, Wang Min, Wang Guodong, Gao Xiaopei, Zhang Lu, Bao Xinwei, Yang Dengfeng, Wang Xiaoying, Zhong Changqing
Department of Gastroenterology, PLA Strategic Support Force Characteristic Medical Center, Beijing, China.
Department of Medical Oncology, The Second Affiliated Hospital of Shandong First Medical University, Taian, China.
Ann Transl Med. 2020 Sep;8(17):1085. doi: 10.21037/atm-20-5622.
Colorectal cancer is among the most prominent malignant tumors endangering human health, with affected populations exhibiting an increasingly younger trend. The () gene acts as a crucial regulator in this disease and influences multiple signaling pathways. In the present study, the gene mutation-induced alteration of intestinal flora in colorectal cancer patients was explored, and the intestinal microbes that may be affected by the gene were examined to provide new insights into the diagnosis and treatment of colorectal cancer.
Deoxyribonucleic acid (DNA) was extracted from 177 colorectal cancer patients in our hospital. The mutation of the gene was subsequently detected using real-time fluorescence quantitative polymerase chain reaction (qPCR), and survival analysis was performed. Moreover, genomic DNA was extracted from the fecal microbes in 30 of these patients, and the differences in the intestinal flora between mutation and non-mutation groups were evaluated using linear discriminant analysis (LDA) Effect size (LEfSe) analysis.
gene mutation substantially affected the distant metastasis of colorectal cancer, and the survival prognosis in the non-mutation group was significantly superior compared to the mutation group. The mutation group had a notably higher prevalence of microbes including Roseburia, Parabacteroides, Metascardovia, Staphylococcus, Staphylococcaceae, and Bacillales than the non-mutation group. The presence of microbes in the non-mutation group, such as Clostridiales, Bacteroidetes, Lachnospiraceae, Coprococcus, and Ruminococcaceae was markedly higher than in the mutation group. Firmicutes were negatively correlated with the presence of Actinomyces and Bacteroidetes, while Bacteroidetes were positively associated with the level of Actinomyces.
In colorectal cancer, gene mutation can remarkably affect the survival prognosis and change the composition and abundance of intestinal flora, such as Roseburia, Parabacteroides, Metascardovia, Staphylococcus, and Bacillales, thereby influencing tumor development.
结直肠癌是危害人类健康的最主要恶性肿瘤之一,患病人群呈年轻化趋势。()基因在该疾病中起关键调节作用,并影响多个信号通路。在本研究中,探讨了结直肠癌患者中该基因突变引起的肠道菌群改变,并检测了可能受该基因影响的肠道微生物,为结直肠癌的诊断和治疗提供新的见解。
从我院177例结直肠癌患者中提取脱氧核糖核酸(DNA)。随后采用实时荧光定量聚合酶链反应(qPCR)检测该基因的突变情况,并进行生存分析。此外,从其中30例患者的粪便微生物中提取基因组DNA,采用线性判别分析效应大小(LEfSe)分析评估突变组和非突变组肠道菌群的差异。
该基因突变显著影响结直肠癌的远处转移,非突变组的生存预后明显优于突变组。与非突变组相比,突变组中包括罗氏菌属、副拟杆菌属、巨心杆菌属、葡萄球菌属、葡萄球菌科和芽孢杆菌目的微生物患病率明显更高。非突变组中梭菌目、拟杆菌门、毛螺菌科、粪球菌属和瘤胃球菌科等微生物的存在明显高于突变组。厚壁菌门与放线菌属和拟杆菌门的存在呈负相关,而拟杆菌门与放线菌属的水平呈正相关。
在结直肠癌中,该基因突变可显著影响生存预后,改变肠道菌群的组成和丰度,如罗氏菌属、副拟杆菌属、巨心杆菌属、葡萄球菌属和芽孢杆菌目,从而影响肿瘤的发展。